Log in to save to my catalogue

Galectin-13 and Laeverin Levels Interfere with Human Fetoplacental Growth

Galectin-13 and Laeverin Levels Interfere with Human Fetoplacental Growth

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11203466

Galectin-13 and Laeverin Levels Interfere with Human Fetoplacental Growth

About this item

Full title

Galectin-13 and Laeverin Levels Interfere with Human Fetoplacental Growth

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2024-06, Vol.25 (12), p.6347

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Galectin-13 (Gal-13) is predominantly produced by the syncytiotrophoblast, while laeverin is expressed on the outgrowing extravillous trophoblast, and both are thought to be biomarkers of preeclampsia. The aim of this study was to assess the correlation between concentrations of Gal-13 and laeverin measured in maternal serum and amniotic fluid at 1...

Alternative Titles

Full title

Galectin-13 and Laeverin Levels Interfere with Human Fetoplacental Growth

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11203466

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11203466

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms25126347

How to access this item